Search - tctmd.com

Displaying 441 - 460 of 532

Sort: Relevancy | Date

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Recent Studies (Including PARTNER) Suggest That Strokes After TAVR Are Declining

Presenter: Susheel Kodali

October 28, 2013

Presentation TCT 2013

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Presenter: Eugene Blackstone

October 28, 2013

Presentation TCT 2013

PARTNER: 3 Years Later, What Have We Learned?

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Highlights of New PARTNER Results from the PARTNER Publications Office

Presenter: E. Murat Tuzcu

October 28, 2013

Presentation TCT 2013

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

Presenter: Martin Leon

October 27, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

中度/重度二尖瓣返流TAVR患者的预后更差

October 11, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

El Abordaje Transfemoral No es la Única Opción para la TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

Yael L. Maxwell

September 27, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

Advertisement

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Recent Studies (Including PARTNER) Suggest That Strokes After TAVR Are Declining

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

PARTNER: 3 Years Later, What Have We Learned?

Highlights of New PARTNER Results from the PARTNER Publications Office

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

中度/重度二尖瓣返流TAVR患者的预后更差

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Transfemoral Access Not Only Option for TAVR

El Abordaje Transfemoral No es la Única Opción para la TAVR

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content